Prediction of Distant Recurrence Using EndoPredict Among Women with ER+, HER2− Node-Positive and Node-Negative Breast Cancer Treated with Endocrine Therapy OnlyMartin Filipits, Michael Gnant, Christian F. Singer et al.|Clinical Cancer Research|2019Cited by 77
Association of Tumor-Infiltrating Lymphocytes with Homologous Recombination Deficiency and <i>BRCA1/2</i> Status in Patients with Early Triple-Negative Breast Cancer: A Pooled AnalysisMelinda L. Telli, Andrea L. Richardson, Charles C. Chu et al.|Clinical Cancer Research|2019Cited by 58
Abstract P4-08-05: Prediction of distant recurrence using EndoPredict among women with ER-positive, HER2-negative breast cancer with a maximum follow-up of 16 yearsMartin Filipits, Michael Gnant, P Dubsky et al.|Cancer Research|2019Cited by 2